Literature DB >> 34534370

Phenotype and genotype of 197 British patients with McArdle disease: An observational single-centre study.

Chiara Pizzamiglio1, Omar A Mahroo2,3,4, Kamron N Khan5,6, Maria Patasin1, Rosaline Quinlivan1.   

Abstract

McArdle disease is caused by recessive mutations in PYGM gene. The condition is considered to cause a "pure" muscle phenotype with symptoms including exercise intolerance, inability to perform isometric activities, contracture, and acute rhabdomyolysis leading to acute renal failure. This is a retrospective observational study aiming to describe phenotypic and genotypic features of a large cohort of patients with McArdle disease between 2011 and 2019. Data relating to genotype and phenotype, including frequency of rhabdomyolysis, fixed muscle weakness, gout and comorbidities, inclusive of retinal disease (pattern retinal dystrophy) and thyroid disease, were collected. Data from 197 patients are presented. Seven previously unpublished PYGM mutations are described. Exercise intolerance (100%) and episodic rhabdomyolysis (75.6%) were the most common symptoms. Fixed muscle weakness was present in 82 (41.6%) subjects. Unexpectedly, ptosis was observed in 28 patients (14.2%). Hyperuricaemia was a common finding present in 88 subjects (44.7%), complicated by gout in 25% of cases. Thyroid dysfunction was described in 30 subjects (15.2%), and in 3 cases, papillary thyroid cancer was observed. Pattern retinal dystrophy was detected in 15 out of the 41 subjects that underwent an ophthalmic assessment (36.6%). In addition to fixed muscle weakness, ptosis was a relatively common finding. Surprisingly, dysfunction of thyroid and retinal abnormalities were relatively frequent comorbidities. Further studies are needed to better clarify this association, although our finding may have important implication for patient management.
© 2021 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.

Entities:  

Keywords:  McArdle disease; comorbidities; muscle glycogen phosphorylase; pattern retinal dystrophy; rhabdomyolysis; thyroid dysfunction

Mesh:

Substances:

Year:  2021        PMID: 34534370     DOI: 10.1002/jimd.12438

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  3 in total

1.  Identification of Potential Muscle Biomarkers in McArdle Disease: Insights from Muscle Proteome Analysis.

Authors:  Inés García-Consuegra; Sara Asensio-Peña; Rocío Garrido-Moraga; Tomàs Pinós; Cristina Domínguez-González; Alfredo Santalla; Gisela Nogales-Gadea; Pablo Serrano-Lorenzo; Antoni L Andreu; Joaquín Arenas; José L Zugaza; Alejandro Lucia; Miguel A Martín
Journal:  Int J Mol Sci       Date:  2022-04-22       Impact factor: 6.208

2.  Whole-exome sequencing detects PYGM variants in two adults with McArdle disease.

Authors:  Amanda Thomas-Wilson; Avinash V Dharmadhikari; Jonas J Heymann; Vaidehi Jobanputra; Salvatore DiMauro; Michio Hirano; Ali B Naini; Mythily Ganapathi
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-03-24

Review 3.  Preclinical Research in McArdle Disease: A Review of Research Models and Therapeutic Strategies.

Authors:  Mónica Villarreal-Salazar; Astrid Brull; Gisela Nogales-Gadea; Antoni L Andreu; Miguel A Martín; Joaquín Arenas; Alfredo Santalla; Alejandro Lucia; John Vissing; Thomas O Krag; Tomàs Pinós
Journal:  Genes (Basel)       Date:  2021-12-28       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.